December 2023 in “bioRxiv (Cold Spring Harbor Laboratory)”
This study found that targeting connectivetissue sheath contraction with an MLCK inhibitor may improve hair growth in androgenetic alopecia by reducing premature hair regression caused by ectopic apoptosis of hairfollicle progenitor cells.
January 1997 in “Han-guk hyeonmigyeong hakoeji/Applied microscopy”
This study observed that the mechanical connection between hairfollicles and connectivetissue in human fetal scalp skin is weaker than in the corresponding skin components, reflecting dynamic processes in hair growth.
14 citations
,
February 2011 in “Experimental dermatology”
This study identifies cartilage oligomeric matrix protein (COMP) as a key extracellular matrix component in human hairfollicle cycling, potentially regulated by TGFβ signaling, and suggests its importance in normal hairfollicle biology.
A 27-year-old male with diffuse hair loss, including the donor area, did not respond to finasteride, dutasteride, or minoxidil. He suspects his hair loss may be linked to a mild connectivetissue disorder, possibly affecting the structural support of hairfollicles, rather than being purely hormonal.
DHT affects hairfollicles, contributing to hair loss, but the exact mechanism is unclear. Treatments like finasteride and minoxidil are used to manage hair loss, though they may have side effects and varying effectiveness.
Hair loss involves more than just DHT, with genetic factors like TRPS affecting hairfollicles. Treatments such as Amplifica's AMP-601 and AMP-303 target stem cells for potential hair growth solutions.
Hair transplantation moves DHT-resistant follicles from a donor area (back and sides of the scalp) into thinning or bald areas. The transplanted hair is generally permanent, though surrounding native hair can keep thinning.